News and Events

Recent Biosimilars Announcement: Open letter to the Premier

September 7, 2019

Dear Premier, Attached please find a copy of an open letter from Dr. Durhane Wong-Rieger on behalf of Consumer Advocare Network to the Premier regarding the subject: Recent.

Continue Reading

Biologic Medicines: Delivering on Their Potential for Patients

December 1, 2017

A joint research report from the International Association of Patients’ Organisations (IAPO) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) Download Full Report

Continue Reading

Crohn’s and Colitis Canada celebrates new treatment options, advocates against Forced Switch

October 5, 2016

TORONTO, Oct. 4, 2016 /CNW/ – In light of upcoming policy decisions that may force patients on certain medications to switch to lower-cost alternatives, Crohn’s and Colitis.

Continue Reading

Canadian Patients Speak Out on Biosimilars

October 3, 2016

TORONTO, Oct. 3, 2016 /CNW/ – Heath Canada has just approved Canada’s sixth biosimilar and suggests we may have up to 60 more biosimilars applications over the next two.

Continue Reading